Page last updated: 2024-10-26

diphenyleneiodonium and Diabetes Mellitus

diphenyleneiodonium has been researched along with Diabetes Mellitus in 2 studies

diphenyleneiodonium: structure in first source; NADPH oxidase inhibitor
dibenziodolium : An organic cation that is fluorene in which the methylene group is replaced by a positively charged iodine.

Diabetes Mellitus: A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Weaver, JR1
Holman, TR1
Imai, Y1
Jadhav, A1
Kenyon, V1
Maloney, DJ1
Nadler, JL1
Rai, G1
Simeonov, A1
Taylor-Fishwick, DA1
Ye, G1
Metreveli, NS1
Ren, J1
Epstein, PN1

Other Studies

2 other studies available for diphenyleneiodonium and Diabetes Mellitus

ArticleYear
Integration of pro-inflammatory cytokines, 12-lipoxygenase and NOX-1 in pancreatic islet beta cell dysfunction.
    Molecular and cellular endocrinology, 2012, Jul-06, Volume: 358, Issue:1

    Topics: Acetophenones; Animals; Apoptosis; Arachidonate 12-Lipoxygenase; Caspase 3; Chemokine CCL2; Diabetes

2012
Metallothionein prevents diabetes-induced deficits in cardiomyocytes by inhibiting reactive oxygen species production.
    Diabetes, 2003, Volume: 52, Issue:3

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Calcium; Diabetes Complications; Diabetes

2003